CPC Class C12Q

Disclosed herein are methods that aid in the diagnosis and evaluation of a human subject that has sustained or may have sustained an injury to the head, such as mild or moderate, severe, or moderate to severe traumatic brain injury (TBI), using cTnI. Also disclosed are methods for determining whether to perform a head computerized tomography on a subject by detecting levels of cTnI. Finally, also disclosed are methods of outcome in subjects suffering from a mild TBI.

Disclosed herein are compositions comprising a CT20 peptide and methods of using the disclosed compositions to treat cancers expressing chaperonin containing TCP (CCT).

The invention provides methods for activating a repressed allele within an imprinting control region, thereby treating an imprinting associated disorder.

A method of treating bladder cancer comprising diagnosing bladder cancer in a human, measuring the human's level of CDKN2A expression, and then instilling into the human an agent which induces interferon expression.

Disclosed herein is a molecular imprinted air filter for removing, detecting and/or reporting specific agents and/or molecules and comprising one or more air-permeable layers of molecular imprinted material positioned to contact molecules and/or agents in an airborne, and/or microdroplet-borne environment, a bioactive molecular imprint of a molecule that captures a specific airborne, fluid borne, and/or microdroplet-borne molecule, particle, or agent, and an electronic enhancement.

Provided herein is a method of performing a nucleic acid sequencing reaction using a sequencing system comprising a reagent cartridge coupled to a detection apparatus, and a pump coupled to the reagent cartridge. The reagent cartridge includes a plurality of reagent reservoirs and a main channel. The detection apparatus includes a flow cell that is coupled to the reagent cartridge when the reagent cartridge interacts transiently with the detection apparatus.